jackin

Advancing medical progress can help more of those in need.

[jackin @jackin528318]

@AjayPaiwal 想要多大的？

[jackin @jackin528318]

$IFRX If the Vilo drug is effective but fails to meet the requirements of the third-phase clinical trials, it would mean the failure of the management team! It has fallen at the same spot three times, wasting many years, and the patients can't wait any longer.

[jackin @jackin528318]

@O248528307 Wasn't the termination of the 25-year PG mid-term analysis trial due to the overly stringent design leading to failure?

[jackin @jackin528318]

$IFRX The Vilo product developed by IFRX in the field of HS COVID PG research has all failed! The post-analysis shows that it was ineffective. The problem lies either in the researchers' capabilities or their lack of clinical design experience.

[jackin @jackin528318]

$IFRX Vilo ANCA？ yes or no ？

[jackin @jackin528318]

Had they collaborated with a larger company, they could have already changed human history.

[jackin @jackin528318]

$IFRX I'm really eager to know if the PG partner that ifrx is looking for has emerged.

[jackin @jackin528318]

#InflaRx why？

[jackin @jackin528318]

#InflaRx On November 15, 2021, ifrx's drug vilobelimab was used to treat AAV. The results of the first and second phases were excellent. Why wasn't the third phase conducted?

[jackin @jackin528318]

@cameron_br_pres The response rate in the placebo group of PG was 16.7% - an exceptionally high figure for a condition where wounds do not heal on their own. This figure speaks for itself.

[jackin @jackin528318]

$IFRX The response rate in the placebo group of PG was 16.7% - an exceptionally high figure for a condition where wounds do not heal on their own. This figure speaks for itself.

[jackin @jackin528318]

@3in5saved If ifrx re-performs the P3 trial with its partners, how long will it take?

[jackin @jackin528318]

#InflaRx $IFRX Up to now, I still don't understand why IFRX Company didn't conduct the third phase of the COVID experiment again. If they had done so, it would have been available on the market by now.

[jackin @jackin528318]

2. When will the results of the BARDA trial for COVID be available? Currently, the two major advantages of IFRX Company are gone, and there are no others...

[jackin @jackin528318]

#InflaRx $IFRX I have a few questions to ask all of you: 1. The ANCA developed by Station Company in China for the Bdb001 injection is currently undergoing phase III trials. If the phase III trials are successful, what impact will it have on IFRX?

[jackin @jackin528318]

@3in5saved @O248528307 The Phase II clinical trial of Barda won't be completed until July 2028. Oh my god, in the coming years, ifrx has no reason for its stock price to soar.

[jackin @jackin528318]

@3in5saved If the Vilo test for pneumonia developed by Barda is successful, will the Vilo test developed by Ifrx be approved in the United States?

[jackin @jackin528318]

#InflaRx If the Vilo test for pneumonia developed by Barda is successful, will the Vilo test developed by Ifrx be approved in the United States?

[jackin @jackin528318]

@O248528307 Who knows at what stage the Barda Vilobelimab COVID trial is and when the results will be released?